Cargando…
Effects of calcifediol supplementation on markers of chronic kidney disease‐mineral and bone disorder in dogs with chronic kidney disease
BACKGROUND: Chronic kidney disease‐mineral and bone disorder (CKD‐MBD) in dogs is associated with hypovitaminosis D, increased parathyroid hormone (PTH), and increased fibroblast growth factor‐23 (FGF‐23) concentrations. Best practice for vitamin D metabolite supplementation in CKD‐MBD remains unkno...
Autores principales: | Parker, Valerie J., Rudinsky, Adam J., Benedict, Jason A., Beizaei, Azadeh, Chew, Dennis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694821/ https://www.ncbi.nlm.nih.gov/pubmed/33128421 http://dx.doi.org/10.1111/jvim.15949 |
Ejemplares similares
-
Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
por: Miller, Matthew, et al.
Publicado: (2022) -
Factors associated with survival in dogs with chronic kidney disease
por: Rudinsky, Adam J., et al.
Publicado: (2018) -
Fibroblast Growth Factor‐23 Concentration in Dogs with Chronic Kidney Disease
por: Harjes, L.M., et al.
Publicado: (2017) -
Association between vitamin D metabolites, vitamin D binding protein, and proteinuria in dogs
por: Miller, Matthew S., et al.
Publicado: (2020) -
Serum uromodulin in dogs with chronic kidney disease
por: Seo, Dansong, et al.
Publicado: (2022)